Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
56,260,480
-
Number of holders
-
41
-
Total 13F shares, excl. options
-
7,677,996
-
Shares change
-
+2,292,465
-
Total reported value, excl. options
-
$11,976,762
-
Value change
-
+$3,808,602
-
Put/Call ratio
-
2.6%
-
Number of buys
-
11
-
Number of sells
-
20
-
Price
-
$1.56
Institutional Holders of Quince Therapeutics, Inc. - Common Stock, par value $0.001 per share (QNCX) as of Q1 2023
As of 31 Mar 2023 Quince Therapeutics, Inc. - Common Stock, par value $0.001 per share (QNCX) had 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 7,677,996 shares of stock of the company.
Largest 10 holders included TANG CAPITAL MANAGEMENT LLC, EPIQ Capital Group, LLC, VANGUARD GROUP INC, TWO SIGMA ADVISERS, LP, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, Alphabet Inc., GEODE CAPITAL MANAGEMENT, LLC, and TWO SIGMA INVESTMENTS, LP.
This table shows 41 institutional shareholders of the security as of 31 Mar 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.